Whole Tumor Cell Vaccine Adjuvants: Comparing IL-12 to IL-2 and IL-15

Whole Tumor Cell Vaccine Adjuvants: Comparing IL-12 to IL-2 and IL-15

Cancer immunotherapy (passive or active) involves treatments which promote the ability of the immune system to fight tumor cells. Several types of immunotherapeutic agents, such as monoclonal antibodies, immune checkpoint inhibitors, non-specific immunomodulatory agents, and cancer vaccines are curr...

Full description

Bibliographic Details
Main Authors: Abdolkarim Sheikhi, Abdollah Jafarzadeh, Parviz Kokhaei, Mohammad Hojjat-Farsangi
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2016-09-01
Series:Iranian Journal of Immunology
Subjects:
cancer
Cytokines
immunotherapy
Tumor Vaccines
Online Access:http://iji.sums.ac.ir/article_33404_23d30245ee6d15da7720424bf5957ee2.pdf

Similar Items

Similar Items